- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
220 results
2010 Exhibit: Hepatitis C Deserves the Attention
Document
IPR2018-00123, No. 2010-23 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2001 Exhibit: Nucleoside Analog Inhibitors of Hepatitis C Virus Replication
Document
IPR2018-00123, No. 2001-14 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2003 Exhibit: FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir
Document
IPR2018-00123, No. 2003-16 Exhibit - FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2008 Exhibit: I MAK Our People
Document
IPR2018-00123, No. 2008-21 Exhibit - I MAK Our People (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2017 Exhibit: Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools f...
Document
IPR2018-00123, No. 2017-27 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Mar. 19, 2...
|
|
Cite Document
2009 Exhibit: Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infe...
Document
IPR2018-00123, No. 2009-22 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2002 Exhibit: Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph
Document
IPR2018-00123, No. 2002-15 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2022 Exhibit: Hepatitis C Virus Replication and Potential Targets for Direct Acting A...
Document
IPR2018-00123, No. 2022-31 Exhibit - Hepatitis C Virus Replication and Potential Targets for Direct Acting Agents (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2005 Exhibit: Hepatitis C Killing More Americans than HIV Studies
Document
IPR2018-00123, No. 2005-18 Exhibit - Hepatitis C Killing More Americans than HIV Studies (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2020 Exhibit: Targets and Tools Recent Advances in the Development of Anti HCV ...
Document
IPR2018-00123, No. 2020-29 Exhibit - Targets and Tools Recent Advances in the Development of Anti HCV Nucleic Acids (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2019 Exhibit: Prodrugs of Phosphates, Phosphonates, and Phosphinates
Document
IPR2018-00123, No. 2019-28 Exhibit - Prodrugs of Phosphates, Phosphonates, and Phosphinates (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2015 Exhibit: Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ C methyluridine Nucleotide Prodru...
Document
IPR2018-00123, No. 2015-26 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ C methyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2012 Exhibit: FDA Approves Gileads Hepatitis C Drug
Document
IPR2018-00123, No. 2012-25 Exhibit - FDA Approves Gileads Hepatitis C Drug (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2003 Exhibit: FDA Approves Game Changer Hepatitis C Drug Sofosbuvir
Document
IPR2018-00123, No. 2003-16 Exhibit - FDA Approves Game Changer Hepatitis C Drug Sofosbuvir (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2017 Exhibit: Pro Nucleotides Recent Advances in the Design of Efficient Tools for ...
Document
IPR2018-00123, No. 2017-27 Exhibit - Pro Nucleotides Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Mar. 19, 201...
|
|
Cite Document
